✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

SMS Pharmaceuticals Ltd.

SMSPHARMA

Market Cap
₹3,651 Cr.
P/E
40.75

SMS Pharmaceuticals Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
3,651 Cr
PE
PE
40.75
Prom Holding
Prom Holding
68.07 %
ROE (%)
ROE (%)
10.81
ROCE (%)
ROCE (%)
13.39
Div Yield (%)
Div Yield (%)
0.10
Sales
Sales
897 Cr
OPM (%)
OPM (%)
19.19 %
Debt to Equity
Debt to Equity
0.50
View more
Edit Ratio's

About

SMS Pharmaceuticals Ltd is one of the leading pharmaceutical manufacturing companies in India … Read more
Low
197
52W Range
High
434
  • SMS Pharmaceuticals
  • Aarti Drugs
  • Supriya Lifescience
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

100 %
(as of Mar 20)
Source/Historic
Migrane Medication Market Share in Mexico

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on SMS Pharmaceuticals Ltd. Business

    SMS Pharmaceuticals Ltd is a leading Indian pharmaceutical manufacturer with state-of-the-art facilities meeting international standards. The company received export house status in 1997-98 and serves a growing global and local customer base.

    SMS Pharmaceuticals major competitors are Aarti Drugs, Supriya Lifescience, Solara Active Pharma, IOL Chem & Pharma, Morepen Laboratories, Aarti Pharmalabs, NGL Fine-Chem.
    Market Cap of SMS Pharmaceuticals is ₹3,651 Crs.
    While the median market cap of its peers are ₹2,328 Crs.

    SMS Pharmaceuticals seems to be less financially stable compared to its competitors.
    Altman Z score of SMS Pharmaceuticals is 6.02 and is ranked 4 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    Discussions & Analysis

    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material